FLSC Stock Forecast: Frazier Life Sciences Acquisition Corp. II Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 5 of 100 as at 4 Nov 2026 — in the weakest quartile.
FLSC stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Frazier Life Sciences Acquisition Corp. II on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (73): Smaller than most of the companies we track.
Issuance (4): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
FLSC stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on FLSC, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
FLSC appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
FLSC analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Frazier Life Sciences Acquisition Corp. II (FLSC) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- 0.0%
- Net margin
- 0.0%
Higher than 32% of US stocks
Higher than 30% of US stocks
- Return on equity
- —
- Return on assets
- —
- Dividend yield
- 0.0%
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Frazier Life Sciences Acquisition Corp. II (FLSC) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Frazier Life Sciences Acquisition Corp. II has a market value of $98.4M and an enterprise value of $0.0.
Forward dividend yield: 0.00%.
Frazier Life Sciences Acquisition Corp. II employs 0 people.
Data provided by Twelve Data
FLSC vs competitors
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| FLSCFrazier Life Sciences Acquisition Corp. II | $98.4M | 5 |
| AACAres Acquisition Corp. III | $98.0M | 6 |
| AMANAmanat Acquisition Corp. | $97.9M | 13 |
| OSPROsprey Acquisition Corp. III | $101.0M | 5 |
| KEYYKeystone Acquisition Corp. /New York/ | $95.2M | 15 |
| TAVITavia Acquisition Corp. | $95.0M | 67 |
| RACDResearch Alliance Corp. IV | $94.6M | 6 |
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Frazier Life Sciences Acquisition Corp. II — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about FLSC stock
How does Ticker Nerd's model rank FLSC?
As at 4 Nov 2026, Frazier Life Sciences Acquisition Corp. II ranks 5 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (73 of 100).
What is the FLSC stock forecast for 2030?
No analyst covering Frazier Life Sciences Acquisition Corp. II publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for FLSC are extrapolating price history, which says nothing about the business.
What does Frazier Life Sciences Acquisition Corp. II do?
Frazier Life Sciences Acquisition Corp. II is a special purpose acquisition company focused on identifying a business in the biotechnology and life sciences sectors for a potential business combination.
About Frazier Life Sciences Acquisition Corp. II.
Frazier Life Sciences Acquisition Corp. II is a special purpose acquisition company focused on identifying a business in the biotechnology and life sciences sectors for a potential business combination. Its search may encompass companies developing innovative therapies, genetic medicines, molecular cancer treatments, drug-discovery platforms, and other healthcare technologies with commercial or clinical applications. Rather than operating manufacturing, distribution, or subscription businesses of its own, the company serves as a corporate vehicle designed to raise capital and evaluate opportunities such as mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar transactions. Its structure provides a publicly traded pathway for a selected private life sciences business to access capital markets and become part of a public company. Frazier Life Sciences Acquisition Corp. II is headquartered in Palo Alto, California, and represents a market-focused investment vehicle within the biotechnology financing landscape, connecting specialized healthcare companies with investors seeking exposure to the sector through a potential combination.
CEO Dr. Albert Cha M.D., Ph.D. · United States